BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16927822)

  • 1. [Mechanism of oral absorption of panaxnotoginseng saponins].
    Han M; Han LM; Wang QS; Bai ZH; Fang XL
    Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
    Han M; Fang XL
    Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models.
    Han M; Sha X; Wu Y; Fang X
    Planta Med; 2006 Apr; 72(5):398-404. PubMed ID: 16557452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between the characteristics of absorption and pharmacokinetic behavior of ginsenoside Rg1 and ginsenoside Rb, of Panax notoginseng saponins].
    Han M; Fu S; Fang XL
    Yao Xue Xue Bao; 2007 Aug; 42(8):849-53. PubMed ID: 17944233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng.
    Xiong J; Guo J; Huang L; Meng B; Ping Q
    Int J Pharm; 2008 Aug; 360(1-2):191-6. PubMed ID: 18502060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].
    Chen G; Mu L; Zhang X; Hou S; Nan H
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1815-20. PubMed ID: 22032151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats.
    Xiong J; Guo J; Huang L; Meng B; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):65-72. PubMed ID: 18214757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro balanced sustained-release of Panax notoginseng saponins controlled with various matrix materials].
    Zhou X; Fu CM; He Y; Zhang JM; Liu HY
    Yao Xue Xue Bao; 2010 Apr; 45(4):505-9. PubMed ID: 21355219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by adrenaline of ginsenoside Rg1 transport in Caco-2 cells and oral absorption in rats.
    Xiong J; Sun M; Guo J; Huang L; Wang S; Meng B; Ping Q
    J Pharm Pharmacol; 2009 Mar; 61(3):347-52. PubMed ID: 19222907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.
    Liu C; Hu M; Guo H; Zhang M; Zhang J; Li F; Zhong Z; Chen Y; Li Y; Xu P; Li J; Liu L; Liu X
    Drug Metab Dispos; 2015 Nov; 43(11):1702-10. PubMed ID: 26265741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on influence factors of gnsenoside Rg1 and Rb1 absorption in intestines of rats].
    Li W; Nan L; Ji Y; Sun X; Sun Z
    Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(20):2627-32. PubMed ID: 20069908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats].
    Takino Y
    Yakugaku Zasshi; 1994 Aug; 114(8):550-64. PubMed ID: 7932100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of Panax notoginsenoside water in oil microemulsion formulations and their evaluation in vitro and in vivo].
    Han M; Fu S; Fang XL
    Yao Xue Xue Bao; 2007 Jul; 42(7):780-6. PubMed ID: 17882965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
    Fan J; Liu D; He C; Li X; He F
    J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
    Zhan S; Guo W; Shao Q; Fan X; Li Z; Cheng Y
    J Ethnopharmacol; 2014 Mar; 152(2):333-9. PubMed ID: 24462784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active absorption of ginsenoside Rg1 in vitro and in vivo: the role of sodium-dependent glucose co-transporter 1.
    Xiong J; Sun M; Guo J; Huang L; Wang S; Meng B; Ping Q
    J Pharm Pharmacol; 2009 Mar; 61(3):381-6. PubMed ID: 19222912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation Procedure and Pharmacokinetic Study of Water-in-Oil Nanoemulsion of Panax Notoginseng Saponins for Improving the Oral Bioavailability.
    Liu Z; Zhang Q; Ding L; Li C; Yin Z; Yan G; Pi J; Li J; Li N; Qi D
    Curr Drug Deliv; 2016; 13(4):600-10. PubMed ID: 26051185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine.
    Liang F; Hua JX
    Eur J Drug Metab Pharmacokinet; 2005; 30(4):261-8. PubMed ID: 16435571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
    Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
    J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of ginsenosides Rg1 and its metabolites in rats].
    Feng L; Hu CJ; Yu LY
    Yao Xue Xue Bao; 2010 May; 45(5):636-40. PubMed ID: 20931768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.